Here's Why Cassava Sciences Is Having a Bad Day

Here's Why Cassava Sciences Is Having a Bad Day

Source: 
Motley Fool
snippet: 
  • The FDA recently received a citizen petition regarding simufilam from a law firm known for class-action suits against publicly traded companies.
  • The allegations center around heavy reliance on a single academic laboratory for positive data regarding simufilam.